Skip to main content

Table 1 Summary of 15 reports of hemophagocytic syndrome after liver transplantation

From: Hemophagocytic syndrome after living donor liver transplantation: a case report with a review of the literature

First author

No.

Age (years)

Sex

Donor type

Diagnosis

Onset

Causes

Treatment

Prognosis

(POD)

G-CSF

IVIg

Steroid

Dialysis

Chemotherapy

Chisuwa (8)

1

9 mo

F

Living

Biliary atresia

15

Unknown

+

+

PE

Etoposide

Died

2

11 mo

M

Living

Biliary atresia

134

EBV

+

+

Died

Hardikar (13)

3

26 mo

M

Deceased

Acute liver failure

15

CMV

+

+

Alive

George (9)

4

10

M

Deceased

Acute liver failure

6 years

EBV

+

+

Etoposide

Alive

Taniai (12)

5

37

F

Living

Unknown

11

Unknown

+

+

PE, CHDF

Died

Karasu (10)

6

38

M

Living

HBV/HDV

124

Unknown

+

+

PE

Alive

Akamatsu (14)

7

48

F

Living

LC/HCV

50

HCV

+

Died

Dharancy (15)

8

49

F

Deceased

polycystic liver/kidney

12

HHV6

Died

Akamatsu (14)

9

49

F

Living

PBC

315

CMV

+

+

PE

Died

Soyama (3)

10

57

M

Living

LC/HCV/HCC

32

CMV/HCC

+

+

+

Died

Akamatsu (14)

11

59

M

Living

LC/HCV

138

Aspergillus

Died

Soyama (3)

12

63

M

Living

LC/HCV/HCC

81

Unknown

+

+

+

Died

Llado (11)

13

63

M

Deceased

Autoimmune hepatitis

NA

Unknown

+

+

Died

Yoshizumi (1)

14

63

M

Living

PBC

13

SFSS

+

+

+

Alive

Present case

15

63

F

Living

HBV

7

SFSS

+

+

+

CHDF

Died

  1. CHDF continuous hemodiafiltration, CMV cytomegalovirus, EBV Epstein-Barr virus, G-CSF granulocyte-colony stimulating factor, HBV hepatitis B virus, HCV hepatitis C virus, HCC hepatocellular carcinoma, HDV hepatitis D virus, HHV6 human herpesvirus 6, IVIg intravenous immunoglobulin, LC liver cirrhosis, mo months, NA not available, PBC primary biliary cholangitis, PE plasma exchange, POD postoperative day, SFSS small-for-size syndrome